What to Consider When Testing for Oncogenic Drivers in NSCLC

What to Consider When Testing for Oncogenic Drivers in NSCLC

What to Consider When Testing for Oncogenic Drivers in NSCLC
RestartResume

What should we keep in mind when testing for oncogenic drivers in patients with non-small cell lung cancer?

  • Overview

    Now that there are more targeted therapies available for metastatic non-small cell lung cancer, what are the best practices for evaluating our patients? Dr. Joshua Bauml elaborates on the opportunities and challenges faced when testing for oncogenic drivers in non-small cell lung cancer.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free